Pulmonary manifestations of ulcerative colitis mimicking Wegener's granulomatosis

Journal of Rheumatology

Volumn 26, Issue 7, 1999, Pages 1617-1621

  Stebbing, Justin ^a   Askin, Frederic ^a   Fishman, Eliot ^a   Stone, John ^a,b  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Antineutrophil cytoplasmic antibodies; Pulmonary disease; Ulcerative colitis; Wegener's granulomatosis

Indexed keywords

NEUTROPHIL CYTOPLASMIC ANTIBODY;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG BIOPSY; PRIORITY JOURNAL; STEROID THERAPY; ULCERATIVE COLITIS; WEGENER GRANULOMATOSIS;

EID: 0033022185     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Greenstein AJ, Sachar DB. The extraintestinal manifestations of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine 1976;55:401-12.
2. Camus P, Piard F, Ashcroft T, Gal AA, Colby TV. The lung in inflammatory bowel disease. Medicine 1993;72:151-83.
3. Salerno SM, Ormseth EJ, Roth BJ, Meyer CA, Christensen ED, Dillard TA. Sulfasalazine pulmonary toxicity in ulcerative colitis mimicking clinical features of Wegener's granulomatosis. Chest 1996;110:556-9.
4. Kraft SC, Earle RH, Roesler M, Esterly JR. Unexplained bronchopulmonary disease with inflammatory bowel disease. Arch Intern Med 1976;136:454-9.
5. Specks U, Homburger HA. Antineutrophil cytoplasmic antibodies. Mayo Clin Proc 1994;69:1197-8.
6. Gaudin PB, Askin FB, Falk RJ, Jennette JC. The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 1995;104:7-16.
7. Saxon A, Shanahan F, Landers C, Ganz T, Targan S. A distinct subset of antineutrophil cytoplasmic antibodies is associated with inflammatory bowel disease. Clin Immunol 1990;86:202-10.
8. Seo M, Okada M, Yao T, Ueki M, Arim S, Okumara M. An index of disease activity in ulcerative colitis. Am J Gastroenterol 1992;87:971-6.
9. Walmsley RS, Zhao MH, Hamilton MI, et al. Antineutrophil cytoplasmic antibodies against bactericidal/permeability-increasing protein in inflammatory bowel disease. Gut 1997;40:105-9.
10. Arditi M, Zhou J, Huang SH, Luckett PM, Marra MN, Kim KS. Bactericidal/permeability-increasing protein protects vascular endothelial cells from lipolysaccharide-induced activation and injury. Infect Immunol 1994;62:3930-6.
11. Hagen EH, Andrassy K, Csernok E, et al. The value of indirect immunofluorescence and solid phase techniques for ANCA detection. J Immunol Methods 1993:159:1-16.
12. Hagen EH, Andrassy K, Csernok E, et al. Development and standardization of solid phase assays for the detection of antineutrophil cytoplasmic antibodies (ANCA): a report on the second phase of an international cooperative study on the standardization of ANCA assays. J Immunol Methods 1996; 196:1-15.
13. Gross W. Antineutrophil cytoplasmic antibody testing in vasculitides. Rheum Dis Clin North Am 1995;21:987-1011.
14. Cho CD, Asuncion A, Tatum AH. False positive antineutrophil cytoplasmic antibody in aspergillosis with oxalosis. Arch Pathol Lab Med 1995;119:558-61.
15. Stappaerts I, Bogers J, Ebo D, Vanden Broecke E, Stevens WJ, Vermeire P. cANCA positivity in a Belgian patient with pulmonary paracoccidioidomycosis. Eur Respir J 1997;10:2419-22.
16. Davenport A, Lock RJ, Wallington TB. Clinical relevance of testing for antineutrophil cytoplasm antibodies (ANCA) with a standard indirect immunofluorescence ANCA test in patients with upper or lower respiratory tract symptoms. Thorax 1994:49:213-7.